A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma

Published:2020-01-02 Issue:2 Volume:99 Page:255-264
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Won Young-Woong,Lee Hyewon,Eom Hyeon-Seok^ORCID,Kim Jin Seok,Suh Cheolwon,Yoon Dok Hyun,Hong Jung Yong,Kang Hye Jin,Lee Jae Hoon,Kim Won Seog,Kim Seok Jin,Lee Won-Sik,Chang Myung Hee,Do Young Rok,Yi Jun Ho,Kim Inho,Won Jong-Ho,Kim Kyoungha,Oh Sung Yong,Jo Jae-Cheol

Funder

Grants of the National Cancer Center

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03891-9.pdf

Reference30 articles.

1. Chisesi T, Bellei M, Luminari S, Montanini A, Marcheselli L, Levis A, Gobbi P, Vitolo U, Stelitano C, Pavone V (2011) Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi. J Clin Oncol 29(32):4227–4233

2. Linch D, Goldstone A, McMillan A, Chopra R, Hudson GV, Winfield D, Hancock B, Moir D, Milligan D (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 341(8852):1051–1054

3. Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M, Boissevain F, Zschaber R, Müller P, Kirchner H (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 359(9323):2065–2071

4. Mendler JH, Friedberg JW (2009) Salvage therapy in Hodgkin's lymphoma. Oncologist 14(4):425–432

5. Bartlett N, Niedzwiecki D, Johnson J, Friedberg J, Johnson K, Van Besien K, Zelenetz A, Cheson B, Canellos G (2007) Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol 18(6):1071–1079

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors;Journal of the National Cancer Center;2023-11

2. Antitumor Effect of Sugar-Modified Cytosine Nucleosides on Growth of Adult T-Cell Leukemia Cells in Mice;Vaccines;2020-11-05